Wy 41747

Wy 41747 is a long-acting Somatostatin analogue. Wy 41747 can be used for the research of diabetes mellitus[1].

Product Specifications

CAS Number

[68463-41-2]

UNSPSC

12352209

Target

Somatostatin Receptor

Type

Peptides

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/wy-41747.html

Solubility

10 mM in DMSO

Smiles

O=C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CSSC[C@H](NC([C@@H](NC([C@](NC([C@@H](NC([C@](NC([C@@H](NC1=O)CCCCN)=O)([H])[C@H](O)C)=O)CC2=CC=CC=C2)=O)([H])[C@H](O)C)=O)CO)=O)C(O)=O)N)=O)CC3=CN=CN3)=O)CC4=CN=CN4)=O)CC5=CC=CC=C5)=O)CC6=CC=CC=C6)N[C@@H]1CC7=CNC8=CC=CC=C78

Molecular Formula

C73H92N18O16S2

Molecular Weight

1541.75

References & Citations

[1]Dimitriadis G, et, al. Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus. Metabolism. 1983 Oct;32 (10) :987-92.